Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors
This study will evaluate the potential immunomodulatory synergy of the association of metronomic cyclophosphamide (CMC) and interferon-alpha (IFN-alpha).
Neuroendocrine Tumors
DRUG: Metronomic cyclophosphamide|DRUG: Interferon-alpha
rate of patients with an immune response defined as "Tregs lymphocytes decrease â‰¥ 20% in blood by the flow cytometry technique", at 3 months of the association CMC and Interferon-alpha
This study will evaluate the potential immunomodulatory synergy of the association of metronomic cyclophosphamide (CMC) and interferon-alpha (IFN-alpha).